Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bingbing Lu

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Oncology|August 28, 2020
Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial AutophagyYifei Xie, Jing Zhang, Bingbing Lu, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 23, 2023
Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growthXuechao Jia, Penglei Wang, Chuntian Huang, et al.
Nature Communications|August 8, 2023
Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancerXuejiao Liu, Simin Zhao, Keke Wang, et al.
Cancer Research|August 26, 2024
Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell CarcinomaLiting Zhou, Jie Tian, Keke Wang, et al.
Signal Transduction and Targeted Therapy|March 5, 2023
Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2Penglei Wang, Xuechao Jia, Bingbing Lu, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Oncology|August 28, 2020
Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial AutophagyYifei Xie, Jing Zhang, Bingbing Lu, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 23, 2023
Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growthXuechao Jia, Penglei Wang, Chuntian Huang, et al.
Nature Communications|August 8, 2023
Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancerXuejiao Liu, Simin Zhao, Keke Wang, et al.
Cancer Research|August 26, 2024
Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell CarcinomaLiting Zhou, Jie Tian, Keke Wang, et al.
Signal Transduction and Targeted Therapy|March 5, 2023
Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2Penglei Wang, Xuechao Jia, Bingbing Lu, et al.
Pageof 3